Pavel Raifeld
Pavel Raifeld is the CEO of Innoviva, where he is committed to making new treatment options like zoliflodacin accessible and affordable for patients globally, particularly in underserved markets, as part of the fight against gonorrhea and other infectious diseases.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 9.00 | 0.04% | +0% | 331,002,651 | 148,033 | $21,000,000 | 9,392$ |
| Totals | 1 | 331,002,651 | 148,033 | $21,000,000 | 9,392$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Pavel Raifeld, Innoviva’s CEO, emphasized the commitment to making their drugs accessible and affordable for patients globally.
9